Business News

Genentech and NVIDIA Form AI Research Collaboration for Drug Discovery and Development

November 29, 2023

Under this multi-year collaboration, Genentech and NVIDIA will use AI to optimize and accelerate each company’s platforms to discover and develop innovative therapeutics.

Lithuania Set to Become Home to Largest Biotech City

November 24, 2023

The largest biotech hub is set to be built in Lithuania by Northway Group.

Industry Responds to the UK’s Autumn Statement

November 23, 2023

UK industry body, ABPI, has responded positively to the recent Autumn Statement.

Novartis and Legend Biotech Sign Exclusive License Agreement for CAR-T Therapies

November 15, 2023

Novartis and Legend Biotech seek to advance certain CAR-T cell therapy candidates targeting Delta-like ligand protein 3.

Salary Survey for Pharma Scientists Shows Increase of 6.7% Since 2022

October 31, 2023

A recent AAPS Salary Survey shows a rising trend in compensation for pharmaceutical scientists since 2022.

CPHI Barcelona: CMOs Expected to Account for 45% Available Bio Capacity in 2027

October 26, 2023

As CMOs continue to invest in cell culture capacity, some are expected to surpass top in-house companies.

Roquette Announces Completion of Qualicaps Acquisition at AAPS PharmSci 360

October 25, 2023

The acquisition of Qualicaps reflects a strategic investment that aims to strengthen Roquette’s global standing in oral dosage solutions.

Royalty Pharma to Purchase up to $1.5 Billion of PTC Therapeutics’ Royalty on Roche’s Evrysdi

October 20, 2023

The spinal muscular atrophy treatment, currently marketed by Roche, generated $1.2 billion in sales in 2022.

Spark Therapeutics Partners with SpliceBio on a Gene Therapy for Eye Disease

October 18, 2023

Spark Therapeutics and SpliceBio have formed a collaboration to develop a gene therapy that can treat an inherited retinal disease.

CIRM Picks Forge Biologics as AAV Manufacturing Partner

October 18, 2023

The California Institute for Regenerative Medicine has partnered with Forge Biologics, which will manufacture AAVs to help accelerate gene therapy programs in California.